Drug Master Files for: arformoterol tartrate
✉ Email this page to a colleague
arformoterol tartrate Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
22968 | A | II | 8/19/2009 | CIPLA LTD | ARFORMOTEROL TARTRATE |
28013 | A | II | 3/15/2014 | MSN LABORATORIES PRIVATE LTD | ARFORMOTEROL TARTRATE [ROUTE CODE - LT] |
28868 | A | II | 3/27/2015 | GLENMARK PHARMACEUTICALS LTD | ARFORMOTEROL TARTRATE |
32990 | A | II | 7/25/2018 | INKE SA | ARFORMOTEROL TARTRATE (FORM D) |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information